Literature DB >> 11935266

Patterns of protein nitration in dementia with Lewy bodies and striatonigral degeneration.

Estrella Gómez-Tortosa1, Isabel Gonzalo, Kathy Newell, Justo García Yébenes, Paul Vonsattel, Bradley T Hyman.   

Abstract

The synucleinopathies are a group of neurodegenerative disorders characterized by the presence of alpha-synuclein inclusions in neurons (Lewy body diseases, LBD) or glial cells (multiple system atrophies, MSA). Recently, nitration of alpha-synuclein has been reported as the possible modification that induces its aggregation and deposition in these disorders. In this study we investigated the distribution and relationships of alpha-synuclein inclusions and 3-nitrotyrosine (3-NT), a marker of protein nitration through oxidative mechanisms, in brains diagnosed with LBD or MSA and control brains using double immunohistochemical techniques. In LBD cases, 3-NT colocalized with alpha-synuclein immunoreactivity in classic and cortical Lewy bodies and in dystrophic neurites in substantia nigra. However, most pale bodies and diffuse deposits in substantia nigra and Lewy neurites in hippocampus lack 3-NT immunoreactivity. A majority of cases showed diffuse cytoplasmic 3-NT staining in pyramidal cells of the CA2-3 regions of the hippocampus that was independent of alpha-synuclein deposits. All MSA cases showed 3-NT immunoreactivity in glial inclusions. 3-NT neuronal staining was restricted to pontine nuclei with three cases showing nuclear and one case cytoplasmic staining. There was no colocalization of 3-NT nuclear immunoreactivity with alpha-synuclein-immunopositive nuclear inclusions in pontine neurons. These data show that protein nitration in LBD and MSA cases has a widespread distribution and is not only associated with the alpha-synuclein deposits. The presence of alpha-synuclein-positive deposits lacking 3-NT immunoreactivity suggests that nitration is not a prerequisite for alpha-synuclein deposition.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11935266     DOI: 10.1007/s00401-001-0495-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  6 in total

1.  Myeloperoxidase inhibition ameliorates multiple system atrophy-like degeneration in a transgenic mouse model.

Authors:  Nadia Stefanova; Biljana Georgievska; Håkan Eriksson; Werner Poewe; Gregor K Wenning
Journal:  Neurotox Res       Date:  2011-12-08       Impact factor: 3.911

Review 2.  Alpha-synuclein: its biological function and role in neurodegenerative diseases.

Authors:  Batia Kaplan; Vladimir Ratner; Elisha Haas
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

3.  Nitration of tau protein is linked to neurodegeneration in tauopathies.

Authors:  Takashi Horiguchi; Kunihiro Uryu; Benoit I Giasson; Harry Ischiropoulos; Richard LightFoot; Christine Bellmann; Christiane Richter-Landsberg; Virginia M-Y Lee; John Q Trojanowski
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

4.  Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains.

Authors:  Douglas G Walker; Lih-Fen Lue; Charles H Adler; Holly A Shill; John N Caviness; Marwan N Sabbagh; Haruhiko Akiyama; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  Exp Neurol       Date:  2012-11-28       Impact factor: 5.330

5.  Mitochondrial inhibitor 3-nitroproprionic acid enhances oxidative modification of alpha-synuclein in a transgenic mouse model of multiple system atrophy.

Authors:  Kiren Ubhi; Phil Hyu Lee; Anthony Adame; Chandra Inglis; Michael Mante; Edward Rockenstein; Nadia Stefanova; Gregor K Wenning; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2009-09       Impact factor: 4.164

6.  Identification and rescue of α-synuclein toxicity in Parkinson patient-derived neurons.

Authors:  Chee Yeun Chung; Vikram Khurana; Pavan K Auluck; Daniel F Tardiff; Joseph R Mazzulli; Frank Soldner; Valeriya Baru; Yali Lou; Yelena Freyzon; Sukhee Cho; Alison E Mungenast; Julien Muffat; Maisam Mitalipova; Michael D Pluth; Nathan T Jui; Birgitt Schüle; Stephen J Lippard; Li-Huei Tsai; Dimitri Krainc; Stephen L Buchwald; Rudolf Jaenisch; Susan Lindquist
Journal:  Science       Date:  2013-10-24       Impact factor: 47.728

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.